MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202621064580 A) filed by Svkm Nmims Global University Dhule on May 22, 2026, for Ligand-Modified Protein-Bound Conjugate Nanoparticle Composition For Pulmonary Delivery”.
Inventors include Dr Vinit Agnihotri; Dr Yatin Gadkari; and Dr Yogeeta Agarwal.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The invention disclosed, the ligand-modified protein-bound conjugate nanoparticle composition comprises at least one therapeutic agent conjugated to a superparamagnetic metal nanoparticle body and at least one protein operatively bound to the nanoparticle body, wherein the protein imparts target-specific binding affinity to the composition. The composition is formulated as a dry powder adapted for pulmonary delivery via inhalation. The dry powder further comprises at least one pharmaceutically acceptable excipient suitable for inhalation delivery and is configured for use in treatment of lung cancer by pulmonary delivery
Disclaimer: Curated by HT Syndication.
